SILEXION THERAPEUTICS CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
SILEXION THERAPEUTICS CORP (SLXN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 20 shares for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2025-11-12
- SILEXION THERAPEUTICS CORP share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- SILEXION THERAPEUTICS CORP share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-06-30 was -268.00 shares.
- SILEXION THERAPEUTICS CORP share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-03-31 was 288.00 shares.
- SILEXION THERAPEUTICS CORP share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-09-30 was 91.23K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month |
|---|---|---|---|
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -268.00 shares derived: sum of 2 quarters · filed 2025-11-12 | 20.00 shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | -268.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 20.00 shares 10-Q · filed 2025-08-12 | |
| 2025-03-31 | 288.00 shares 10-Q · filed 2025-05-13 | ||
| 2024-09-30 | 91.23K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 121.42K shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 30.18K shares 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |